<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/633"/><api:result><api:object category="publication" id="633" last-affected-when="2024-03-14T05:56:04.043+00:00" last-modified-when="2024-03-14T05:56:04.043+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/633" created-when="2010-05-17T13:46:24.47+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2009-01-30</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1491457" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1038/sj.bjp.0702892" last-modified-when="2023-11-04T02:41:11.627+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;jats:p&gt;
&lt;jats:list list-type="explicit-label"&gt;
&lt;jats:list-item&gt;&lt;jats:p&gt;Incubation of human eosinophils in BSA‐coated tissue culture plates resulted in time‐dependent adhesion and attendant activation of the NADPH oxidase that were both inhibited (by &amp;gt;85%) by blocking antibodies raised against CD11b and CD18.&lt;/jats:p&gt;&lt;/jats:list-item&gt;
&lt;jats:list-item&gt;&lt;jats:p&gt;SB 203580, an inhibitor of p38 mitogen‐activated protein (MAP) kinase, did not influence adhesion but inhibited superoxide anion generation (pIC&lt;jats:sub&gt;50&lt;/jats:sub&gt;=−6.57).&lt;/jats:p&gt;&lt;/jats:list-item&gt;
&lt;jats:list-item&gt;&lt;jats:p&gt;PP1, an inhibitor of the src‐family of protein tyrosine kinases, inhibited adhesion and CD11b/CD18‐mediated superoxide anion generation with similar potencies (pEC&lt;jats:sub&gt;50&lt;/jats:sub&gt;s=−5.53 and −5.99 respectively) suggesting that inhibition of the NADPH oxidase was a direct consequence of blocking adhesion.&lt;/jats:p&gt;&lt;/jats:list-item&gt;
&lt;jats:list-item&gt;&lt;jats:p&gt;The protein kinase C (PKC) inhibitors Ro‐31 8220 (broad spectrum inhibitor), GF 109203X (inhibitor of conventional and novel isoforms) and Gö 6976 (inhibitor of conventional isoforms) suppressed adhesion‐dependent NADPH oxidase activation (pIC&lt;jats:sub&gt;50&lt;/jats:sub&gt;s=−6.61, −6.05 and −4.89 respectively) without affecting adhesion. Based upon the selectivity of these drugs PKCδ and PKCε are implicated in the suppression of oxidant production.&lt;/jats:p&gt;&lt;/jats:list-item&gt;
&lt;jats:list-item&gt;&lt;jats:p&gt;Wortmannin, an inhibitor of phosphatidylinositol 3‐kinase (PtdIns 3‐kinase), abolished superoxide anion production in adherent eosinophils (pEC&lt;jats:sub&gt;50&lt;/jats:sub&gt;=−9.06). Similarly, CD11b/CD18‐dependent adhesion was suppressed with the same potency (pEC&lt;jats:sub&gt;50&lt;/jats:sub&gt;=−9.29) although the maximum effect did not exceed 50% implying that wortmannin also had an affect on those processes that govern adhesion‐driven oxidase activation.&lt;/jats:p&gt;&lt;/jats:list-item&gt;
&lt;jats:list-item&gt;&lt;jats:p&gt;PD 098059 and piceatannol, inhibitors of MAP kinase kinase‐1 and the syk tyrosine kinase respectively, had no effect on CD11b/CD18‐mediated adhesion or NADPH oxidase activation.&lt;/jats:p&gt;&lt;/jats:list-item&gt;
&lt;jats:list-item&gt;&lt;jats:p&gt;The results of this study demonstrate that human eosinophils adhere to BSA‐coated plastic by a CD11b/CD18‐dependent mechanism, which is responsible for activation of the NADPH oxidase. Although the signalling pathway(s) utilized by CD11b/CD18 is still to be elucidated, the data presented herein implicate p38 MAP kinase, novel PKCs and PtdIns 3‐kinase.&lt;/jats:p&gt;&lt;/jats:list-item&gt;
&lt;/jats:list&gt;
&lt;/jats:p&gt;&lt;jats:p&gt;&lt;jats:italic&gt;British Journal of Pharmacology&lt;/jats:italic&gt; (1999) &lt;jats:bold&gt;128&lt;/jats:bold&gt;, 1149–1158; doi:&lt;jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1038/sj.bjp.0702892"&gt;10.1038/sj.bjp.0702892&lt;/jats:ext-link&gt;&lt;/jats:p&gt;</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Lynch</api:last-name><api:initials>OT</api:initials><api:first-names>Oonagh T</api:first-names><api:separate-first-names><api:first-name>Oonagh</api:first-name><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Giembycz</api:last-name><api:initials>MA</api:initials><api:first-names>Mark A</api:first-names><api:separate-first-names><api:first-name>Mark</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Barnes</api:last-name><api:initials>PJ</api:initials><api:first-names>Peter J</api:first-names><api:separate-first-names><api:first-name>Peter</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>Paul G</api:first-names><api:separate-first-names><api:first-name>Paul</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lindsay</api:last-name><api:initials>MA</api:initials><api:first-names>Mark A</api:first-names><api:separate-first-names><api:first-name>Mark</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjp.0702892</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjp.0702892"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjp.0702892"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1476-5381</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Pharmacology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>30</api:day><api:month>1</api:month><api:year>2009</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1149</api:begin-page><api:end-page>1158</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1038/sj.bjp.0702892</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>29</api:day><api:month>10</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>‘Outside‐in’ signalling mechanisms underlying CD11b/CD18‐mediated NADPH oxidase activation in human adherent blood eosinophils</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>128</api:text></api:field></api:native></api:record><api:record format="native" id="420350" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0032711991" last-modified-when="2022-01-05T18:03:30.473+00:00"><api:citation-count>45</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>1. Incubation of human eosinophils in BSA-coated tissue culture plates resulted in time-dependent adhesion and attendant activation of the NADPH oxidase that were both inhibited (by &gt; 85%) by blocking antibodies raised against CD11b and CD18. 2. SB 203580, an inhibitor of p38 mitogen-activated protein (MAP) kinase, did not influence adhesion but inhibited superoxide anion generation (pIC50 = -6.57). 3. PP1, an inhibitor of the src-family of protein tyrosine kinases, inhibited adhesion and CD11b/CD18-mediated superoxide anion generation with similar potencies (pEC50s = -5.53 and -5.99 respectively) suggesting that inhibition of the NADPH oxidase was a direct consequence of blocking adhesion. 4. The protein kinase C (PKC) inhibitors Ro-31 8220 (broad spectrum inhibitor), GF 109203X (inhibitor of conventional and novel isoforms) and Go 6976 (inhibitor of conventional isoforms) suppressed adhesion-dependent NADPH oxidase activation (pIC50s = -6.61, -6.05 and -4.89 respectively) without affecting adhesion. Based upon the selectivity of these drugs PRCδ and PKCε are implicated in the suppression of oxidant production. 5. Wortmannin, an inhibitor of phosphatidylinositol 3-kinase (PtdIns 3-kinase), abolished superoxide anion production in adherent eosinophils (pEC50 = -9.06). Similarly, CD11b/CD18-dependent adhesion was suppressed with the same potency (pEC50 = -9.29) although the maximum effect did not exceed 50% implying that wortmannin also had an affect on those processes that govern adhesion-driven oxidase activation. 6. PD 098059 and piceatannol, inhibitors of MAP kinase kinase-1 and the syk tyrosine kinase respectively, had no effect on CD11b/CD18-mediated adhesion or NADPH oxidase activation. 7. The results of this study demonstrate that human eosinophils adhere to BSA-coated plastic by a CD11b/CD18-dependent mechanism, which is responsible for activation of the NADPH oxidase. Although the signalling pathway(s) utilized by CD11b/CD18 is still to be elucidated, the data presented herein implicate p38 MAP kinase, novel PKCs and PtdIns 3-kinase.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Lynch</api:last-name><api:initials>OT</api:initials><api:first-names>OT</api:first-names><api:separate-first-names><api:first-name>O</api:first-name><api:first-name>T</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London School of Medicine</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6602569054</api:identifier></api:identifiers></api:person><api:person><api:last-name>Giembycz</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London School of Medicine</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7007035171</api:identifier></api:identifiers></api:person><api:person><api:last-name>Barnes</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London School of Medicine</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">36064679400</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>PG</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005788575</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lindsay</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London School of Medicine</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7102822713</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjp.0702892</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjp.0702892"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjp.0702892"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10578126</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Pharmacology</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1149</api:begin-page><api:end-page>1158</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>'Outside-in' signalling mechanisms underlying CD11b/CD18-mediated NADPH oxidase activation in human adherent blood eosinophils</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>128</api:text></api:field></api:native></api:record><api:record format="native" id="633" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10578126" last-modified-when="2022-11-22T22:55:45.827+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>1 Incubation of human eosinophils in BSA-coated tissue culture plates resulted in time-dependent adhesion and attendant activation of the NADPH oxidase that were both inhibited (by &gt;85%) by blocking antibodies raised against CD11b and CD18. 2 SB 203580, an inhibitor of p38 mitogen-activated protein (MAP) kinase, did not influence adhesion but inhibited superoxide anion generation (pIC50=-6.57). 3 PP1, an inhibitor of the src-family of protein tyrosine kinases, inhibited adhesion and CD11b/CD18-mediated superoxide anion generation with similar potencies (pEC50s=-5.53 and -5.99 respectively) suggesting that inhibition of the NADPH oxidase was a direct consequence of blocking adhesion. 4 The protein kinase C (PKC) inhibitors Ro-31 8220 (broad spectrum inhibitor), GF 109203X (inhibitor of conventional and novel isoforms) and Gö 6976 (inhibitor of conventional isoforms) suppressed adhesion-dependent NADPH oxidase activation (pIC50s=-6.61, -6.05 and -4.89 respectively) without affecting adhesion. Based upon the selectivity of these drugs PKCdelta and PKCepsilon are implicated in the suppression of oxidant production. 5 Wortmannin, an inhibitor of phosphatidylinositol 3-kinase (PtdIns 3-kinase), abolished superoxide anion production in adherent eosinophils (pEC50=-9.06). Similarly, CD11b/CD18-dependent adhesion was suppressed with the same potency (pEC50=-9.29) although the maximum effect did not exceed 50% implying that wortmannin also had an affect on those processes that govern adhesion-driven oxidase activation. 6 PD 098059 and piceatannol, inhibitors of MAP kinase kinase-1 and the syk tyrosine kinase respectively, had no effect on CD11b/CD18-mediated adhesion or NADPH oxidase activation. 7 The results of this study demonstrate that human eosinophils adhere to BSA-coated plastic by a CD11b/CD18-dependent mechanism, which is responsible for activation of the NADPH oxidase. Although the signalling pathway(s) utilized by CD11b/CD18 is still to be elucidated, the data presented herein implicate p38 MAP kinase, novel PKCs and PtdIns 3-kinase.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Lynch</api:last-name><api:initials>OT</api:initials><api:first-names>OT</api:first-names><api:separate-first-names><api:first-name>O</api:first-name><api:first-name>T</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Thoracic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, Dovehouse Street, London SW3 6LY.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Giembycz</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Barnes</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>PG</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lindsay</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10578126</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjp.0702892</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjp.0702892"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjp.0702892"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC1571741</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Br J Pharmacol</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Androstadienes</api:keyword><api:keyword scheme="mesh">CD18 Antigens</api:keyword><api:keyword scheme="mesh">Carbazoles</api:keyword><api:keyword scheme="mesh">Cell Adhesion</api:keyword><api:keyword scheme="mesh">Cell Count</api:keyword><api:keyword scheme="mesh">Dose-Response Relationship, Drug</api:keyword><api:keyword scheme="mesh">Enzyme Activation</api:keyword><api:keyword scheme="mesh">Enzyme Inhibitors</api:keyword><api:keyword scheme="mesh">Eosinophils</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Imidazoles</api:keyword><api:keyword scheme="mesh">Indoles</api:keyword><api:keyword scheme="mesh">Isoenzymes</api:keyword><api:keyword scheme="mesh">Macrophage-1 Antigen</api:keyword><api:keyword scheme="mesh">Maleimides</api:keyword><api:keyword scheme="mesh">Mitogen-Activated Protein Kinases</api:keyword><api:keyword scheme="mesh">N-Formylmethionine Leucyl-Phenylalanine</api:keyword><api:keyword scheme="mesh">NADPH Oxidases</api:keyword><api:keyword scheme="mesh">Phosphatidylinositol 3-Kinases</api:keyword><api:keyword scheme="mesh">Phosphoinositide-3 Kinase Inhibitors</api:keyword><api:keyword scheme="mesh">Protein Kinase C</api:keyword><api:keyword scheme="mesh">Pyrazoles</api:keyword><api:keyword scheme="mesh">Pyridines</api:keyword><api:keyword scheme="mesh">Pyrimidines</api:keyword><api:keyword scheme="mesh">Signal Transduction</api:keyword><api:keyword scheme="mesh">Superoxides</api:keyword><api:keyword scheme="mesh">Tetradecanoylphorbol Acetate</api:keyword><api:keyword scheme="mesh">Wortmannin</api:keyword><api:keyword scheme="mesh">p38 Mitogen-Activated Protein Kinases</api:keyword><api:keyword scheme="mesh">src-Family Kinases</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1149</api:begin-page><api:end-page>1158</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>0702892</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>24</api:day><api:month>1</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>'Outside-in' signalling mechanisms underlying CD11b/CD18-mediated NADPH oxidase activation in human adherent blood eosinophils.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Comparative Study</api:item><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>128</api:text></api:field></api:native></api:record><api:record format="native" id="881956" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10578126" last-modified-when="2023-11-21T18:56:44.33+00:00"><api:citation-count>30</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>1 Incubation of human eosinophils in BSA-coated tissue culture plates resulted in time-dependent adhesion and attendant activation of the NADPH oxidase that were both inhibited (by &gt;85%) by blocking antibodies raised against CD11b and CD18. 2 SB 203580, an inhibitor of p38 mitogen-activated protein (MAP) kinase, did not influence adhesion but inhibited superoxide anion generation (pIC50=-6.57). 3 PP1, an inhibitor of the src-family of protein tyrosine kinases, inhibited adhesion and CD11b/CD18-mediated superoxide anion generation with similar potencies (pEC50s=-5.53 and -5.99 respectively) suggesting that inhibition of the NADPH oxidase was a direct consequence of blocking adhesion. 4 The protein kinase C (PKC) inhibitors Ro-31 8220 (broad spectrum inhibitor), GF 109203X (inhibitor of conventional and novel isoforms) and Gö 6976 (inhibitor of conventional isoforms) suppressed adhesion-dependent NADPH oxidase activation (pIC50s=-6.61, -6.05 and -4.89 respectively) without affecting adhesion. Based upon the selectivity of these drugs PKCdelta and PKCepsilon are implicated in the suppression of oxidant production. 5 Wortmannin, an inhibitor of phosphatidylinositol 3-kinase (PtdIns 3-kinase), abolished superoxide anion production in adherent eosinophils (pEC50=-9.06). Similarly, CD11b/CD18-dependent adhesion was suppressed with the same potency (pEC50=-9.29) although the maximum effect did not exceed 50% implying that wortmannin also had an affect on those processes that govern adhesion-driven oxidase activation. 6 PD 098059 and piceatannol, inhibitors of MAP kinase kinase-1 and the syk tyrosine kinase respectively, had no effect on CD11b/CD18-mediated adhesion or NADPH oxidase activation. 7 The results of this study demonstrate that human eosinophils adhere to BSA-coated plastic by a CD11b/CD18-dependent mechanism, which is responsible for activation of the NADPH oxidase. Although the signalling pathway(s) utilized by CD11b/CD18 is still to be elucidated, the data presented herein implicate p38 MAP kinase, novel PKCs and PtdIns 3-kinase.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Thoracic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, Dovehouse Street, London SW3 6LY.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Lynch</api:last-name><api:initials>OT</api:initials><api:first-names>OT</api:first-names><api:separate-first-names><api:first-name>O</api:first-name><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Giembycz</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Barnes</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-5122-4018</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>PG</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lindsay</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0003-4807-5506</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjp.0702892</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjp.0702892"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjp.0702892"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1476-5381</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10578126</api:identifier><api:identifier scheme="pmc">PMC1571741</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British journal of pharmacology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Eosinophils</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Superoxides</api:keyword><api:keyword scheme="mesh">Maleimides</api:keyword><api:keyword scheme="mesh">Tetradecanoylphorbol Acetate</api:keyword><api:keyword scheme="mesh">Imidazoles</api:keyword><api:keyword scheme="mesh">Pyrazoles</api:keyword><api:keyword scheme="mesh">Pyridines</api:keyword><api:keyword scheme="mesh">Pyrimidines</api:keyword><api:keyword scheme="mesh">Indoles</api:keyword><api:keyword scheme="mesh">Carbazoles</api:keyword><api:keyword scheme="mesh">Androstadienes</api:keyword><api:keyword scheme="mesh">Isoenzymes</api:keyword><api:keyword scheme="mesh">Mitogen-Activated Protein Kinases</api:keyword><api:keyword scheme="mesh">p38 Mitogen-Activated Protein Kinases</api:keyword><api:keyword scheme="mesh">Protein Kinase C</api:keyword><api:keyword scheme="mesh">src-Family Kinases</api:keyword><api:keyword scheme="mesh">N-Formylmethionine Leucyl-Phenylalanine</api:keyword><api:keyword scheme="mesh">Macrophage-1 Antigen</api:keyword><api:keyword scheme="mesh">Enzyme Inhibitors</api:keyword><api:keyword scheme="mesh">Cell Count</api:keyword><api:keyword scheme="mesh">Cell Adhesion</api:keyword><api:keyword scheme="mesh">Signal Transduction</api:keyword><api:keyword scheme="mesh">Enzyme Activation</api:keyword><api:keyword scheme="mesh">Dose-Response Relationship, Drug</api:keyword><api:keyword scheme="mesh">Phosphatidylinositol 3-Kinases</api:keyword><api:keyword scheme="mesh">CD18 Antigens</api:keyword><api:keyword scheme="mesh">NADPH Oxidases</api:keyword><api:keyword scheme="mesh">Wortmannin</api:keyword><api:keyword scheme="mesh">Phosphoinositide-3 Kinase Inhibitors</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1149</api:begin-page><api:end-page>1158</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>1</api:day><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>'Outside-in' signalling mechanisms underlying CD11b/CD18-mediated NADPH oxidase activation in human adherent blood eosinophils.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Comparative Study</api:item><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>research-article</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>128</api:text></api:field><api:files><api:file proprietary-id="https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0702892"><api:file-url>https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0702892</api:file-url><api:extension>pdf</api:extension><api:is-open-access>true</api:is-open-access><api:file-version>Published version</api:file-version></api:file><api:file proprietary-id="https://europepmc.org/articles/PMC1571741?pdf=render"><api:file-url>https://europepmc.org/articles/PMC1571741?pdf=render</api:file-url><api:extension>pdf</api:extension><api:is-open-access>true</api:is-open-access><api:file-version>Published version</api:file-version></api:file></api:files></api:native></api:record><api:record format="native" id="2516990" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1010410858" last-modified-when="2024-01-04T12:39:07.65+00:00"><api:citation-count>42</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Lynch</api:last-name><api:initials>OT</api:initials><api:first-names>Oonagh T</api:first-names><api:separate-first-names><api:first-name>Oonagh</api:first-name><api:first-name>T</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0711276641.20</api:identifier></api:identifiers></api:person><api:person><api:last-name>Giembycz</api:last-name><api:initials>MA</api:initials><api:first-names>Mark A</api:first-names><api:separate-first-names><api:first-name>Mark</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01217070422.22</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person><api:person><api:last-name>Barnes</api:last-name><api:initials>PJ</api:initials><api:first-names>Peter J</api:first-names><api:separate-first-names><api:first-name>Peter</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01045564377.55</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>Paul G</api:first-names><api:separate-first-names><api:first-name>Paul</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0745306034.38</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lindsay</api:last-name><api:initials>MA</api:initials><api:first-names>Mark A</api:first-names><api:separate-first-names><api:first-name>Mark</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01011555302.31</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjp.0702892</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjp.0702892"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjp.0702892"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10578126</api:identifier><api:identifier scheme="pmc">PMC1571741</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Pharmacology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">3208 Medical Physiology</api:keyword><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="mesh">Androstadienes</api:keyword><api:keyword scheme="mesh">CD18 Antigens</api:keyword><api:keyword scheme="mesh">Carbazoles</api:keyword><api:keyword scheme="mesh">Cell Adhesion</api:keyword><api:keyword scheme="mesh">Cell Count</api:keyword><api:keyword scheme="mesh">Dose-Response Relationship, Drug</api:keyword><api:keyword scheme="mesh">Enzyme Activation</api:keyword><api:keyword scheme="mesh">Enzyme Inhibitors</api:keyword><api:keyword scheme="mesh">Eosinophils</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Imidazoles</api:keyword><api:keyword scheme="mesh">Indoles</api:keyword><api:keyword scheme="mesh">Isoenzymes</api:keyword><api:keyword scheme="mesh">Macrophage-1 Antigen</api:keyword><api:keyword scheme="mesh">Maleimides</api:keyword><api:keyword scheme="mesh">Mitogen-Activated Protein Kinases</api:keyword><api:keyword scheme="mesh">N-Formylmethionine Leucyl-Phenylalanine</api:keyword><api:keyword scheme="mesh">NADPH Oxidases</api:keyword><api:keyword scheme="mesh">Phosphatidylinositol 3-Kinases</api:keyword><api:keyword scheme="mesh">Phosphoinositide-3 Kinase Inhibitors</api:keyword><api:keyword scheme="mesh">Protein Kinase C</api:keyword><api:keyword scheme="mesh">Pyrazoles</api:keyword><api:keyword scheme="mesh">Pyridines</api:keyword><api:keyword scheme="mesh">Pyrimidines</api:keyword><api:keyword scheme="mesh">Signal Transduction</api:keyword><api:keyword scheme="mesh">Superoxides</api:keyword><api:keyword scheme="mesh">Tetradecanoylphorbol Acetate</api:keyword><api:keyword scheme="mesh">Wortmannin</api:keyword><api:keyword scheme="mesh">p38 Mitogen-Activated Protein Kinases</api:keyword><api:keyword scheme="mesh">src-Family Kinases</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>30</api:day><api:month>1</api:month><api:year>2009</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Bronze OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1149</api:begin-page><api:end-page>1158</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.91</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>‘Outside‐in’ signalling mechanisms underlying CD11b/CD18‐mediated NADPH oxidase activation in human adherent blood eosinophils</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>128</api:text></api:field></api:native></api:record><api:record format="native" id="240938" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000083929800004" last-modified-when="2024-03-14T05:56:04.05+00:00"><api:citation-count>43</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Lynch</api:last-name><api:initials>OT</api:initials><api:first-names>OT</api:first-names><api:separate-first-names><api:first-name>O</api:first-name><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Giembycz</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Barnes</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>PG</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lindsay</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000083929800004&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjp.0702892</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjp.0702892"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjp.0702892"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">260CB</api:identifier><api:identifier scheme="pubmed">10578126</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRITISH JOURNAL OF PHARMACOLOGY</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>human adherent eosinophils</api:keyword><api:keyword>'outside-in' signalling</api:keyword><api:keyword>protein kinase C</api:keyword><api:keyword>p38 MAP kinase</api:keyword><api:keyword>adhesion (CD11b/CD18)-dependent NADPH oxidase activation</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1149</api:begin-page><api:end-page>1158</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>'Outside-in' signalling mechanisms underlying CD11b/CD18-mediated NADPH oxidase activation in human adherent blood eosinophils</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>128</api:text></api:field></api:native></api:record><api:record format="native" id="23795" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000083929800004" last-modified-when="2014-07-25T11:04:42.28+01:00"><api:citation-count>33</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Lynch</api:last-name><api:initials>OT</api:initials><api:first-names>OT</api:first-names><api:separate-first-names><api:first-name>O</api:first-name><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Giembycz</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Barnes</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="934" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/934"/></api:links><api:last-name>Hellewell</api:last-name><api:initials>PG</api:initials><api:first-names>PG</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lindsay</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1188</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRIT J PHARMACOL</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>human adherent eosinophils</api:keyword><api:keyword>'outside-in' signalling</api:keyword><api:keyword>protein kinase C</api:keyword><api:keyword>p38 MAP kinase</api:keyword><api:keyword>adhesion (CD11b/CD18)-dependent NADPH oxidase activation</api:keyword><api:keyword>PROTEIN-KINASE-C</api:keyword><api:keyword>VASCULAR ENDOTHELIAL-CELLS</api:keyword><api:keyword>SRC FAMILY KINASES</api:keyword><api:keyword>HUMAN NEUTROPHILS</api:keyword><api:keyword>TYROSINE KINASE</api:keyword><api:keyword>RESPIRATORY BURST</api:keyword><api:keyword>ADHESION MOLECULE-1</api:keyword><api:keyword>INHIBITOR</api:keyword><api:keyword>PHOSPHORYLATION</api:keyword><api:keyword>FIBRONECTIN</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1149</api:begin-page><api:end-page>1158</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>'Outside-in' signalling mechanisms underlying CD11b/CD18-mediated NADPH oxidase activation in human adherent blood eosinophils</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>128</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Androstadienes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">CD18 Antigens</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Carbazoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cell Adhesion</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cell Count</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Dose-Response Relationship, Drug</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Enzyme Activation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Enzyme Inhibitors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Eosinophils</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Imidazoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Indoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Isoenzymes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Macrophage-1 Antigen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Maleimides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Mitogen-Activated Protein Kinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">N-Formylmethionine Leucyl-Phenylalanine</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">NADPH Oxidases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Phosphatidylinositol 3-Kinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Phosphoinositide-3 Kinase Inhibitors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Protein Kinase C</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Pyrazoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Pyridines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Pyrimidines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Signal Transduction</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Superoxides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tetradecanoylphorbol Acetate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Wortmannin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">p38 Mitogen-Activated Protein Kinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">src-Family Kinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Eosinophils</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Superoxides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Maleimides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tetradecanoylphorbol Acetate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Imidazoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Pyrazoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Pyridines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Pyrimidines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Indoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Carbazoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Androstadienes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Isoenzymes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Mitogen-Activated Protein Kinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">p38 Mitogen-Activated Protein Kinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Protein Kinase C</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">src-Family Kinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">N-Formylmethionine Leucyl-Phenylalanine</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Macrophage-1 Antigen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Enzyme Inhibitors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cell Count</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cell Adhesion</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Signal Transduction</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Enzyme Activation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Dose-Response Relationship, Drug</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Phosphatidylinositol 3-Kinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">CD18 Antigens</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">NADPH Oxidases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Wortmannin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Phosphoinositide-3 Kinase Inhibitors</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3208 Medical Physiology</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Androstadienes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">CD18 Antigens</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Carbazoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cell Adhesion</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cell Count</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Dose-Response Relationship, Drug</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Enzyme Activation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Enzyme Inhibitors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Eosinophils</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Imidazoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Indoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Isoenzymes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Macrophage-1 Antigen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Maleimides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Mitogen-Activated Protein Kinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">N-Formylmethionine Leucyl-Phenylalanine</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">NADPH Oxidases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Phosphatidylinositol 3-Kinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Phosphoinositide-3 Kinase Inhibitors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Protein Kinase C</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Pyrazoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Pyridines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Pyrimidines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Signal Transduction</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Superoxides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tetradecanoylphorbol Acetate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Wortmannin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">p38 Mitogen-Activated Protein Kinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">src-Family Kinases</api:keyword><api:keyword origin="record-data" source="wos-lite">human adherent eosinophils</api:keyword><api:keyword origin="record-data" source="wos-lite">'outside-in' signalling</api:keyword><api:keyword origin="record-data" source="wos-lite">protein kinase C</api:keyword><api:keyword origin="record-data" source="wos-lite">p38 MAP kinase</api:keyword><api:keyword origin="record-data" source="wos-lite">adhesion (CD11b/CD18)-dependent NADPH oxidase activation</api:keyword><api:keyword origin="record-data" source="wos">human adherent eosinophils</api:keyword><api:keyword origin="record-data" source="wos">'outside-in' signalling</api:keyword><api:keyword origin="record-data" source="wos">protein kinase C</api:keyword><api:keyword origin="record-data" source="wos">p38 MAP kinase</api:keyword><api:keyword origin="record-data" source="wos">adhesion (CD11b/CD18)-dependent NADPH oxidase activation</api:keyword><api:keyword origin="record-data" source="wos">PROTEIN-KINASE-C</api:keyword><api:keyword origin="record-data" source="wos">VASCULAR ENDOTHELIAL-CELLS</api:keyword><api:keyword origin="record-data" source="wos">SRC FAMILY KINASES</api:keyword><api:keyword origin="record-data" source="wos">HUMAN NEUTROPHILS</api:keyword><api:keyword origin="record-data" source="wos">TYROSINE KINASE</api:keyword><api:keyword origin="record-data" source="wos">RESPIRATORY BURST</api:keyword><api:keyword origin="record-data" source="wos">ADHESION MOLECULE-1</api:keyword><api:keyword origin="record-data" source="wos">INHIBITOR</api:keyword><api:keyword origin="record-data" source="wos">PHOSPHORYLATION</api:keyword><api:keyword origin="record-data" source="wos">FIBRONECTIN</api:keyword><api:keyword scheme="for" origin="issn-inferred">1115 Pharmacology and Pharmaceutical Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Pharmacology &amp; Pharmacy</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3214 Pharmacology and pharmaceutical sciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0007-1188" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/972940" title="British Journal of Pharmacology"><api:records><api:record source-name="summary"><api:title>British Journal of Pharmacology</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/633/relationships"/></api:object></api:result></api:response>